Landmark Financial Advisors’s Amgen AMGN Stock Holding History

Landmark Financial Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-838	Closed	-$203K	–	91
2023 Q1	$203K	Sell	838 -40	-5%	-$9.82K	0.09%	86
2022 Q4	$231K	Sell	878 -10	-1%	-$2.68K	0.11%	82
2022 Q3	$200K	Hold	888	–	–	0.11%	79
2022 Q2	$216K	Sell	888 -30	-3%	-$7.35K	0.11%	77
2022 Q1	$231K	Buy	+918	New	+$211K	0.11%	78

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Landmark Financial Advisors's AMGN Position: Q2 2023 in Review

Landmark Financial Advisors sold out of Amgen (AMGN) in Q2 2023, closing a stake of 838 shares — an estimated $203K sold.

Landmark Financial Advisors first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $231K in Q1 2022. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

Landmark Financial Advisors reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
Landmark Financial Advisors sold 838 Amgen shares in Q2 2023, an estimated $203K.
Landmark Financial Advisors first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
Landmark Financial Advisors's Amgen position peaked at $231K in Q1 2022.
2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Landmark Financial Advisors's 13F filing for Q2 2023, filed 18 Jul 2023.